On April 12, 2024, Clover Biopharmaceuticals, Ltd closed the transaction. The transaction included participation from 10 investors, which includes a single non-accredited investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 HKD | -2.63% | -2.63% | -40.32% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.32% | 63.09M | |
+18.15% | 124B | |
+18.02% | 112B | |
+3.29% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-16.71% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding